{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:34:25Z","timestamp":1788885265732,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.cgh.2017.02.029","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T13:03:11Z","timestamp":1488891791000},"page":"1382-1389.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide"],"prefix":"10.1016","volume":"15","author":[{"given":"Marzia","family":"Lazzerini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Villanacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Pellegrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Martelossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Magazz\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Lucanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrigo","family":"Barabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Calvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Arrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Zuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8201-2416","authenticated-orcid":false,"given":"Giuseppe","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bramuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Maschio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Salemme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Manenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-2955","authenticated-orcid":false,"given":"Luisa","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Decorti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Montico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2017.02.029_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/apt.13475","article-title":"Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease","volume":"43","author":"Shah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.02.029_bib2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cgh.2016.01.015","article-title":"Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis","volume":"14","author":"Shah","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.02.029_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11894-013-0315-7","article-title":"Deep remission in inflammatory bowel disease: looking beyond symptoms","volume":"15","author":"Zallot","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2017.02.029_bib4","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3748\/wjg.v19.i7.968","article-title":"Histological healing in inflammatory bowel disease: a still unfulfilled promise","volume":"19","author":"Villanacci","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.029_bib5","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.crohns.2014.08.011","article-title":"Systematic review: histological remission in inflammatory bowel disease. Is \u2018complete' remission the new treatment paradigm? An IOIBD initiative","volume":"8","author":"Bryant","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2017.02.029_bib6","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.2013.280777","article-title":"Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial","volume":"310","author":"Lazzerini","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2017.02.029_bib7","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/MIB.0000000000000437","article-title":"Effect of thalidomide on clinical remission in children and adolescents with ulcerative colitis refractory to other immunosuppressives: pilot randomised clinical trial","volume":"21","author":"Lazzerini","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2017.02.029_bib8","doi-asserted-by":"crossref","first-page":"e4239","DOI":"10.1097\/MD.0000000000004239","article-title":"Thalidomide for inflammatory bowel disease: systematic review","volume":"95","author":"Bramuzzo","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2017.02.029_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/01.mpg.0000183350.46795.42","article-title":"Evaluation of the pediatric Crohn\u2019s disease activity index: a prospective multicenter experience","volume":"41","author":"Hyams","year":"2005","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2017.02.029_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study","volume":"133","author":"Turner","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.029_bib11","doi-asserted-by":"crossref","first-page":"1625e9","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5- aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.02.029_bib12","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/gut.33.12.1644","article-title":"Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease","volume":"33","author":"Wardle","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.029_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.MIB.0000437986.00190.71","article-title":"Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices","volume":"20","author":"Mosli","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2017.02.029_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum","volume":"114","author":"D'Haens","year":"1998","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.cgh.2017.02.029_bib15","first-page":"A767","article-title":"Thalidomide-effective therapy in chronic resistant inflammatory bowel disease [abstract]","volume":"116","author":"Macumber","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.029_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1440-1746.2002.02564.x","article-title":"Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease","volume":"17","author":"Bariol","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.02.029_bib17","first-page":"178","article-title":"Efficacy of long-term treatment with thalidomide in children and young adults with Crohn\u2019s disease: preliminary results","volume":"32","author":"Facchini","year":"2001","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2017.02.029_bib18","article-title":"An open trail of thalidomide in refractory Crohn\u2019s colitis","author":"Trebble","year":"2001","journal-title":"Presented at the Annual Meeting British Society of Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.029_bib19","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.3748\/wjg.v17.i45.5028","article-title":"Thalidomide induces mucosal healing in Crohn's disease: case report","volume":"17","author":"Leite","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.029_bib20","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3748\/wjg.v17.i10.1286","article-title":"Treatment of pediatric refractory Crohn's disease with thalidomide","volume":"17","author":"Zheng","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.029_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MCG.0000000000000122","article-title":"Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-\u03b1 drugs: report of 3 cases and literature review","volume":"48","author":"Scribano","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.029_bib22","first-page":"214","article-title":"Thalidomide for the treatment of oral aphthous ulcers in Crohn\u2019s disease","volume":"28","author":"Weinstein","year":"1999","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2017.02.029_bib23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1046\/j.1365-2036.2002.01273.x","article-title":"An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn\u2019s disease","volume":"16","author":"Sabate","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.02.029_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clinre.2016.09.012","article-title":"Thalidomide is a therapeutic agent that is effective in inducing and maintaining endoscopic remission in adult CD patients","volume":"41","author":"Zhu","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.029_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2017.02.029_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1086\/314834","article-title":"Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group","volume":"180","author":"Jacobson","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cgh.2017.02.029_bib27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1086\/515222","article-title":"Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial","volume":"28","author":"Ramirez-Amador","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2017.02.029_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1086\/317928","article-title":"Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers","volume":"183","author":"Jacobson","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cgh.2017.02.029_bib29","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V96.12.3995","article-title":"Thalidomide for treatment of patients with chronic graft-versus-host disease","volume":"96","author":"Koc","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2017.02.029_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.bmt.1701138","article-title":"The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children","volume":"21","author":"Rovelli","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cgh.2017.02.029_bib31","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","volume":"363","author":"Franks","year":"2004","journal-title":"Thalidomide. Lancet"},{"key":"10.1016\/j.cgh.2017.02.029_bib32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/07853890108995961","article-title":"Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature","volume":"33","author":"Ginsburg","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.cgh.2017.02.029_bib33","first-page":"521","article-title":"Thalidomide use in pediatric patients","volume":"36","author":"Bessmertny","year":"2002","journal-title":"Ann Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.02.029_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1517\/14740338.3.1.47","article-title":"Thalidomide: an old drug with new clinical applications","volume":"3","author":"Laffitte","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.cgh.2017.02.029_bib35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00003495-200161060-00006","article-title":"Thalidomide in gastrointestinal disorders","volume":"61","author":"Bousvaros","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.cgh.2017.02.029_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/gut.50.2.196","article-title":"Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn\u2019s disease","volume":"50","author":"Bauditz","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.029_bib37","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.02.029_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gie.2005.08.011","article-title":"Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn\u2019s disease","volume":"63","author":"Rutgeerts","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2017.02.029_bib39","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.02.029_bib40","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2012.01.035","article-title":"Adalimumab induces and maintains mucosal healing in patients with Crohn\u2019s disease: data from the EXTENDtrial","volume":"142","author":"Rutgeerts","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.029_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2011.10.032","article-title":"Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis","volume":"142","author":"Sandborn","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.029_bib42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517302604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517302604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:23:49Z","timestamp":1761542629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356517302604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1542356517302604"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2017.02.029","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2017.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}